Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.531 Q1 | 103 | 84 | 319 | 11035 | 1560 | 286 | 4.51 | 131.37 | 42.98 | |
2 | Current Medicinal Chemistry | journal | 0.903 Q1 | 202 | 432 | 892 | 53007 | 3275 | 828 | 3.62 | 122.70 | 44.94 | |
3 | Current Cancer Drug Targets | journal | 0.893 Q1 | 103 | 81 | 240 | 6341 | 652 | 219 | 2.62 | 78.28 | 42.96 | |
4 | CNS and Neurological Disorders - Drug Targets | journal | 0.832 Q2 | 96 | 75 | 356 | 5805 | 1004 | 308 | 3.28 | 77.40 | 42.50 | |
5 | Current Topics in Medicinal Chemistry | journal | 0.788 Q2 | 133 | 231 | 798 | 22201 | 2546 | 687 | 2.90 | 96.11 | 40.28 | |
6 | Current Gene Therapy | journal | 0.782 Q2 | 80 | 44 | 128 | 2998 | 283 | 115 | 2.29 | 68.14 | 40.22 | |
7 | Current Drug Targets | journal | 0.741 Q2 | 119 | 139 | 552 | 15568 | 1470 | 500 | 2.63 | 112.00 | 40.24 | |
8 | Current Molecular Pharmacology | journal | 0.629 Q2 | 49 | 28 | 98 | 2442 | 237 | 85 | 2.87 | 87.21 | 44.53 | |
9 | Current Pharmaceutical Design | journal | 0.606 Q2 | 183 | 450 | 1768 | 47168 | 4305 | 1639 | 2.23 | 104.82 | 42.01 | |
10 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.603 Q2 | 52 | 29 | 94 | 2940 | 250 | 91 | 2.75 | 101.38 | 44.35 | |
11 | Current Vascular Pharmacology | journal | 0.559 Q3 | 69 | 51 | 261 | 3613 | 489 | 216 | 2.13 | 70.84 | 34.62 | |
12 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.543 Q3 | 108 | 198 | 590 | 11794 | 1247 | 566 | 1.98 | 59.57 | 43.53 | |
13 | Mini-Reviews in Medicinal Chemistry | journal | 0.500 Q2 | 107 | 120 | 425 | 10067 | 1162 | 394 | 2.65 | 83.89 | 36.87 | |
14 | Current Clinical Pharmacology | journal | 0.475 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
15 | Current Radiopharmaceuticals | journal | 0.447 Q3 | 32 | 34 | 90 | 1777 | 173 | 82 | 2.19 | 52.26 | 35.80 | |
16 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.436 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
17 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.399 Q3 | 28 | 0 | 28 | 0 | 42 | 24 | 0.63 | 0.00 | 0.00 | |
18 | Reviews on Recent Clinical Trials | journal | 0.361 Q3 | 35 | 43 | 129 | 1922 | 141 | 116 | 1.21 | 44.70 | 41.25 | |
19 | Current Drug Delivery | journal | 0.359 Q2 | 72 | 84 | 403 | 5455 | 676 | 384 | 1.53 | 64.94 | 45.28 | |
20 | Medicinal Chemistry | journal | 0.344 Q3 | 50 | 82 | 254 | 4430 | 481 | 248 | 2.24 | 54.02 | 43.45 | |
21 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.330 Q3 | 45 | 27 | 69 | 2335 | 104 | 65 | 1.42 | 86.48 | 40.31 | |
22 | Current Drug Safety | journal | 0.304 Q3 | 41 | 45 | 124 | 1237 | 148 | 117 | 1.36 | 27.49 | 38.96 | |
23 | Current Drug Discovery Technologies | journal | 0.297 Q3 | 49 | 50 | 78 | 2745 | 101 | 75 | 1.29 | 54.90 | 39.56 | |
24 | Combinatorial Chemistry and High Throughput Screening | journal | 0.296 Q3 | 70 | 82 | 287 | 3127 | 376 | 259 | 1.22 | 38.13 | 35.29 | |
25 | Current Pharmaceutical Analysis | journal | 0.286 Q2 | 27 | 89 | 218 | 2773 | 185 | 212 | 0.87 | 31.16 | 47.28 | |
26 | Recent Patents on Drug Delivery and Formulation | journal | 0.277 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
27 | Infectious Disorders - Drug Targets | journal | 0.267 Q3 | 61 | 54 | 89 | 2210 | 95 | 82 | 1.10 | 40.93 | 48.73 | |
28 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.251 Q3 | 27 | 12 | 52 | 490 | 53 | 48 | 1.04 | 40.83 | 34.09 | |
29 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.246 Q3 | 43 | 17 | 58 | 665 | 64 | 51 | 1.31 | 39.12 | 32.00 | |
30 | Current Nanoscience | journal | 0.246 Q2 | 52 | 72 | 245 | 4405 | 392 | 229 | 1.88 | 61.18 | 35.04 | |
31 | Letters in Drug Design and Discovery | journal | 0.240 Q2 | 37 | 115 | 445 | 5038 | 468 | 436 | 1.15 | 43.81 | 42.42 | |
32 | Current Bioactive Compounds | journal | 0.236 Q2 | 31 | 68 | 140 | 3473 | 138 | 130 | 1.11 | 51.07 | 43.50 | |
33 | Drug Metabolism Letters | journal | 0.233 Q2 | 31 | 14 | 76 | 675 | 78 | 67 | 1.03 | 48.21 | 40.00 | |
34 | Open Medicinal Chemistry Journal | journal | 0.220 Q3 | 23 | 6 | 31 | 245 | 49 | 29 | 1.59 | 40.83 | 38.24 | |
35 | Current Computer-Aided Drug Design | journal | 0.216 Q4 | 32 | 40 | 105 | 1649 | 86 | 90 | 0.80 | 41.23 | 31.82 | |
36 | Current Enzyme Inhibition | journal | 0.204 Q4 | 19 | 20 | 64 | 609 | 40 | 59 | 0.68 | 30.45 | 45.16 | |
37 | Current Drug Therapy | journal | 0.160 Q3 | 20 | 21 | 44 | 1450 | 25 | 41 | 0.47 | 69.05 | 47.56 | |
38 | Recent Patents on CNS Drug Discovery | journal | 0.156 Q4 | 36 | 0 | 18 | 0 | 14 | 17 | 0.00 | 0.00 | 0.00 | |
39 | Anti-Infective Agents | journal | 0.155 Q4 | 26 | 17 | 58 | 628 | 31 | 53 | 0.39 | 36.94 | 44.00 | |
40 | Current Metabolomics | journal | 0.144 Q4 | 4 | 0 | 6 | 0 | 4 | 5 | 0.00 | 0.00 | 0.00 | |
41 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.131 Q4 | 17 | 0 | 44 | 0 | 17 | 40 | 0.44 | 0.00 | 0.00 | |
42 | Current Pharmacogenomics and Personalized Medicine | journal | 0.116 Q4 | 20 | 0 | 52 | 0 | 15 | 45 | 0.32 | 0.00 | 0.00 | |
43 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 27 | 103 | 1372 | 191 | 95 | 1.85 | 50.81 | 33.68 | ||
44 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 8 | 49 | 404 | 60 | 44 | 1.03 | 50.50 | 22.22 | ||
45 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 33 | 61 | 2538 | 81 | 56 | 1.21 | 76.91 | 39.62 | ||
46 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 17 | 45 | 1636 | 102 | 43 | 1.93 | 96.24 | 33.33 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®